Aniracetam vs Pramiracetam for focus
Short answer: For focus, more users report improvement with Pramiracetam — 95% of 91 reports, versus 85% of 200 for Aniracetam.
Aniracetam has 1 meta-analyses and 9 randomized trials on PubMed; Pramiracetam has 0 and 3.
Based on 899 reports about Aniracetam and 343 about Pramiracetam. Not medical advice.
| Aniracetam Supplement | Pramiracetam Supplement | |
|---|---|---|
| Users say it helped | 60%helped405 reports · high confidence | 59%helped127 reports · high confidence |
| Verdict | Mostly positive | Mixed |
| Research | BResearch: Moderate | CResearch: Limited |
| Meta-analyses / RCTs | 1 / 9 | 0 / 3 |
| Mainly used for | ||
| Focus % reporting improvement | 85% (200) | 95% (91) |
| Anxiety % reporting improvement | 92% (191) | 100% (8) |
| Mood % reporting improvement | 87% (100) | 45% (22) |
| Memory % reporting improvement | 85% (55) | 95% (38) |
| Energy % reporting improvement | 64% (22) | 91% (11) |
| Common side effects | drowsiness, irritability, fatigue, headache | headache, emotional blunting, fatigue, bad taste |
| Typical dose reported | 750 mg | 1 teaspoon |
The most effective intervention for dementia available is symptomatic treatment for vascular dementia. Antipsychotic treatment for dementia alleviates cognitive dysfunction less effectively than does symptomatic treatment. Alternative therapies are also effective at present. Further research on causes and very early diagnosis of Alzheimer disease is warranted.
Psychopharmacology (Berl), 2018 ↗“Aniracetam: Anecdotally I could feel instantaneous mental improvement within 2-3 days... The most significant improvement was attention... organization, and confidence.”
“I was very anxious and listless for a while and the substances that helped me the most were Pramiracetam + alpha GPC.”
Related comparisons
Percentages come from first-hand user reports and are not clinical outcomes. Talk to a doctor before starting, stopping or combining anything. How we rate